Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 7, 2024; 30(9): 999-1004
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.999
Role of albumin-bilirubin score in non-malignant liver disease
Shi-Xue Xu, Fan Yang, Nan Ge, Jin-Tao Guo, Si-Yu Sun
Shi-Xue Xu, Fan Yang, Nan Ge, Jin-Tao Guo, Si-Yu Sun, Department of Gastroenterology, Engineering Research Center of Ministry of Education for Minimally Invasive Gastrointestinal Endoscopic Techniques, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China
Author contributions: Xu SX, Yang F, Ge N, Guo JT, and Sun SY contributed to this study; Xu SX and Sun SY designed the overall concept and outline of the manuscript; Yang F, Ge N, and Guo JT contributed to the discussion and design of the manuscript; Xu SX and Yang F contributed to the writing and editing of the manuscript, illustrations, and review of the literature.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Si-Yu Sun, MD, PhD, Professor, Department of Gastroenterology, Engineering Research Center of Ministry of Education for Minimally Invasive Gastrointestinal Endoscopic Techniques, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang 110004, Liaoning Province, China. sunsy@sj-hospital.org
Received: December 14, 2023
Peer-review started: December 14, 2023
First decision: January 4, 2024
Revised: January 12, 2024
Accepted: February 18, 2024
Article in press: February 18, 2024
Published online: March 7, 2024
Core Tip

Core Tip: The application of albumin-bilirubin score in liver diseases is not limited to hepatocellular carcinoma. In addition to predicting disease progression, it can also be used to predict survival in other non-malignant liver diseases.